Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Octave Bioscience Inc See All Filings	D	2025-03-24 09:19:17 UTC
Amount To Be Raised $53,674,121 Associated Brokers / Dealers N/A CIK Number 0001702278 Filed Document 0001702278-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-03-24 09:19:17 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Octave Bioscience Inc See All Filings	D	2023-11-24 16:53:40 UTC
Amount To Be Raised $6,999,999 Associated Brokers / Dealers N/A CIK Number 0001702278 Filed Document 0001702278-23-000003 Exclusions or Exemptions 506b Accepted Date 2023-11-24 16:53:40 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Octave Bioscience Inc See All Filings	D	2023-11-24 16:45:02 UTC
Amount To Be Raised $37,505,524 Associated Brokers / Dealers N/A CIK Number 0001702278 Filed Document 0001702278-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-11-24 16:45:02 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Octave Bioscience Inc See All Filings	D	2021-01-06 21:35:38 UTC
Amount To Be Raised $32,000,000 Associated Brokers / Dealers N/A CIK Number 0001702278 Filed Document 0001702278-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-01-06 21:35:38 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Octave Bioscience Inc See All Filings	D	2017-09-13 13:28:40 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0001702278 Filed Document 0001702278-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-09-13 13:28:40 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity